- Home
- Publications
- Publication Search
- Publication Details
Title
Antibiotics in development targeting protein synthesis
Authors
Keywords
-
Journal
Annals of the New York Academy of Sciences
Volume 1241, Issue 1, Pages 122-152
Publisher
Wiley
Online
2011-12-23
DOI
10.1111/j.1749-6632.2011.06323.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activity of ACHN-490 Tested Alone and in Combination with Other Agents against Pseudomonas aeruginosa
- (2011) Glenn A. Pankuch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects
- (2011) Robert T. Cass et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoEfficacy of the Novel Aminoglycoside ACHN-490 in Murine Infection Models
- (2011) Noe Reyes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects
- (2011) J. Gordon Still et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cethromycin-Mediated Protection against the Plague Pathogen Yersinia pestis in a Rat Model of Infection and Comparison with Levofloxacin
- (2011) Jason A. Rosenzweig et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacteriophages Carrying Antibiotic Resistance Genes in Fecal Waste from Cattle, Pigs, and Poultry
- (2011) Marta Colomer-Lluch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New antimicrobial agents on the horizon
- (2011) Karen Bush et al. BIOCHEMICAL PHARMACOLOGY
- Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital
- (2011) Chih-Ming Chen et al. BMC MICROBIOLOGY
- Pharmacokinetics and Safety of Single, Multiple, and Loading Doses of Fusidic Acid in Healthy Subjects
- (2011) J. G. Still et al. CLINICAL INFECTIOUS DISEASES
- Efforts to Support the Development of Fusidic Acid in the United States
- (2011) P. Fernandes et al. CLINICAL INFECTIOUS DISEASES
- A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2011) J. Carl Craft et al. CLINICAL INFECTIOUS DISEASES
- Application of Pharmacokinetic-Pharmacodynamic Modeling and the Justification of a Novel Fusidic Acid Dosing Regimen: Raising Lazarus From the Dead
- (2011) Brian T. Tsuji et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Antimicrobial Findings for Fusidic Acid Tested Against Contemporary (2008–2009) Gram-Positive Organisms Collected in the United States
- (2011) Ronald N. Jones et al. CLINICAL INFECTIOUS DISEASES
- Evaluation of the pharmacokinetics–pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection
- (2011) Olanrewaju O. Okusanya et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals
- (2011) Fred C. Tenover et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibiotics in the clinical pipeline in 2011
- (2011) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Determination of CEM-101 Activity Tested against Clinical Isolates of Neisseria meningitidis from a Worldwide Collection
- (2010) D. J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal Mutations
- (2010) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Characterization of Off-Target Activities of Telithromycin: a Potential Role for Nicotinic Acetylcholine Receptors
- (2010) D. Bertrand et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cellular Pharmacokinetics of the Novel Biaryloxazolidinone Radezolid in Phagocytic Cells: Studies with Macrophages and Polymorphonuclear Neutrophils
- (2010) S. Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, Using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila
- (2010) S. Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis
- (2010) B. Llano-Sotelo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CEM-101 Activity against Gram-Positive Organisms
- (2010) L. N. Woosley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Antimicrobial Activities of Torezolid (TR-700), the Active Moiety of a New Oxazolidinone, Torezolid Phosphate (TR-701), Determination of Tentative Disk Diffusion Interpretive Criteria, and Quality Control Ranges
- (2010) S. D. Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antistaphylococcal Activity of ACHN-490 Tested Alone and in Combination with Other Agents by Time-Kill Assay
- (2010) G. Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and Spectrum of the Neoglycoside ACHN-490
- (2010) J. B. Aggen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combating evolution with intelligent design: the neoglycoside ACHN-490
- (2010) Eliana S Armstrong et al. CURRENT OPINION IN MICROBIOLOGY
- Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102)
- (2010) Douglas J. Biedenbach et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates
- (2010) David J. Farrell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
- (2010) Shannon D. Putnam et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)
- (2010) David J. Farrell et al. JOURNAL OF INFECTION
- Origins and Evolution of Antibiotic Resistance
- (2010) J. Davies et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Intrinsic resistance to aminoglycosides in Enterococcus faecium is conferred by the 16S rRNA m5C1404-specific methyltransferase EfmM
- (2010) M. Galimand et al. RNA
- In Vitro Activity of CEM-101, a New Fluoroketolide Antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae
- (2009) P. M. Roblin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Susceptibilities of Human Mycoplasmas and Ureaplasmas to a New Investigational Ketolide, CEM-101
- (2009) K. B. Waites et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages
- (2009) S. Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)
- (2009) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria
- (2009) Shannon D. Putnam et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines
- (2009) S. Lemaire et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008
- (2009) S. N. Patel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens
- (2008) L. Lawrence et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- R -01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance
- (2008) E. Skripkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design at the atomic level: Design of biaryloxazolidinones as potent orally active antibiotics
- (2008) Jiacheng Zhou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design at the atomic level: Generation of novel hybrid biaryloxazolidinones as promising new antibiotics
- (2008) Jiacheng Zhou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Susceptibility of 170 isolates of the USA300 clone of MRSA to macrolides, clindamycin and the novel ketolide cethromycin
- (2008) V. A. Luna et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation